Junaid Abdulghani

883 total citations
14 papers, 739 citations indexed

About

Junaid Abdulghani is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Junaid Abdulghani has authored 14 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Junaid Abdulghani's work include Cell death mechanisms and regulation (5 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Prostate Cancer Treatment and Research (4 papers). Junaid Abdulghani is often cited by papers focused on Cell death mechanisms and regulation (5 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Prostate Cancer Treatment and Research (4 papers). Junaid Abdulghani collaborates with scholars based in United States, Finland and Switzerland. Junaid Abdulghani's co-authors include Wafik S. El‐Deiry, Marja T. Nevalainen, Ayush Dagvadorj, Tuomas Mirtti, Kalle Alanen, Tobias Zellweger, Lukas Bubendorf, Tapio Visakorpi, Lei Gu and Benjamin E. Leiby and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Junaid Abdulghani

14 papers receiving 724 citations

Peers

Junaid Abdulghani

ONCOL

PRM

IMMUN

Carmela De Marco Italy

Yukiko Shibahara Japan

Núria Eritja Spain

María C. Díaz Flaqué Argentina

Russell Ericksen United States

Eftihia Cocolakis Canada

Ira Kogan-Sakin Israel

Holger H.H. Erb Germany

Zhibo Yang China

Francesco Caiazza Ireland

Carmela De Marco Italy

Junaid Abdulghani

691 ×1.6

336 ×1.0

ONCOL

242 ×1.5

195 ×1.2

PRM

86 ×0.9

IMMUN

Citations per year, relative to Junaid Abdulghani Junaid Abdulghani (= 1×) peers Carmela De Marco

Countries citing papers authored by Junaid Abdulghani

Since Specialization

Citations

This map shows the geographic impact of Junaid Abdulghani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junaid Abdulghani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junaid Abdulghani more than expected).

Fields of papers citing papers by Junaid Abdulghani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junaid Abdulghani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junaid Abdulghani. The network helps show where Junaid Abdulghani may publish in the future.

Co-authorship network of co-authors of Junaid Abdulghani

This figure shows the co-authorship network connecting the top 25 collaborators of Junaid Abdulghani. A scholar is included among the top collaborators of Junaid Abdulghani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junaid Abdulghani. Junaid Abdulghani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Abdulghani, Junaid, Jean‐Nicolas Gallant, David T. Dicker, et al.. (2016). Sorafenib and Quinacrine Target Anti-Apoptotic Protein MCL1: A Poor Prognostic Marker in Anaplastic Thyroid Cancer (ATC). Clinical Cancer Research. 22(24). 6192–6203. 35 indexed citations

Gu, Lei, Paraskevi Vogiatzi, Ana L. Romero-Weaver, et al.. (2014). Pharmacologic Suppression of JAK1/2 by JAK1/2 Inhibitor AZD1480 Potently Inhibits IL-6–Induced Experimental Prostate Cancer Metastases Formation. Molecular Cancer Therapeutics. 13(5). 1246–1258. 35 indexed citations

Abdulghani, Junaid, Joshua E. Allen, David T. Dicker, et al.. (2013). Sorafenib Sensitizes Solid Tumors to Apo2L/TRAIL and Apo2L/TRAIL Receptor Agonist Antibodies by the Jak2-Stat3-Mcl1 Axis. PLoS ONE. 8(9). e75414–e75414. 42 indexed citations

Abdulghani, Junaid, et al.. (2012). Impact of Genetic Targets on Prostate Cancer Therapy. Advances in experimental medicine and biology. 779. 359–383. 2 indexed citations

Goyal, Neerav, et al.. (2012). Molecular and Genetic Markers of Follicular-Cell Thyroid Cancer: Etiology and Diagnostic and Therapeutic Opportunities. Advances in experimental medicine and biology. 779. 309–326. 10 indexed citations

Mirtti, Tuomas, Benjamin E. Leiby, Junaid Abdulghani, et al.. (2012). Nuclear Stat5a/b predicts early recurrence and prostate cancer–specific death in patients treated by radical prostatectomy. Human Pathology. 44(3). 310–319. 38 indexed citations

Mirtti, Tuomas, Benjamin E. Leiby, Pär Stattin, et al.. (2012). Abstract C41: Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy.. Cancer Research. 72(4_Supplement). C41–C41. 2 indexed citations

Wang, Wenge, Jean‐Nicolas Gallant, Sharyn I. Katz, et al.. (2011). Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents. Cancer Biology & Therapy. 12(3). 229–238. 44 indexed citations

Abdulghani, Junaid & Wafik S. El‐Deiry. (2010). TRAIL receptor signaling and therapeutics. Expert Opinion on Therapeutic Targets. 14(10). 1091–1108. 129 indexed citations

10.

Wang, Wenge, Sharyn I. Katz, Junaid Abdulghani, David T. Dicker, & Wafik S. El‐Deiry. (2010). Abstract 680: Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL via up-regulating DR5 and eradicating MCL-1. Cancer Research. 70(8_Supplement). 680–680. 1 indexed citations

11.

Tan, Shyh‐Han, Ayush Dagvadorj, Feng Shen, et al.. (2008). Transcription Factor Stat5 Synergizes with Androgen Receptor in Prostate Cancer Cells. Cancer Research. 68(1). 236–248. 88 indexed citations

12.

Abdulghani, Junaid, Lei Gu, Ayush Dagvadorj, et al.. (2008). Stat3 Promotes Metastatic Progression of Prostate Cancer. American Journal Of Pathology. 172(6). 1717–1728. 198 indexed citations

13.

Dagvadorj, Ayush, Sean P. Collins, J Jomain, et al.. (2007). Autocrine Prolactin Promotes Prostate Cancer Cell Growth via Janus Kinase-2-Signal Transducer and Activator of Transcription-5a/b Signaling Pathway. Endocrinology. 148(7). 3089–3101. 105 indexed citations

14.

Misra, Smita, et al.. (2005). A type II ribonuclease H from Leishmania mitochondria: An enzyme essential for the growth of the parasite. Molecular and Biochemical Parasitology. 143(2). 135–145. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact